Skip to content

Reclaimtm 10-165-4016

by Depuy (Ireland)

Reclaimtm 10-165-4016 (101654016) is a device of GMDN type press-fit hip femur prosthesis (FDA Class II; FDA product code LZO) made by Depuy (Ireland), listed in FDA GUDID since 25 Jul 2025 (UDI-DI 10603295554202), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number10603295554202 UDI-DI Date25 Jul 2025ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
RECLAIMTM MONOBLOC REVISION FEMORAL STEM SHORT STEM STANDARD OFFSET SO 16 CEMENTLESS
MRI safety
MR Conditional
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Reclaimtm
Generic name
Press-fit hip femur prosthesis, one-piece
Model / Ref / Catalog
10-165-4016, 101654016
Primary DI / UDI-DI
10603295554202
FDA product code
LZO
GMDN term
Press-fit hip femur prosthesis, one-piece
Device class
Class II
Regulation number
888.3353
GUDID distribution status
In Commercial Distribution
MRI safety
MR Conditional

Similar devices

Other devices filed under FDA product code LZO (Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous, uncemented).

Other devices from Depuy (Ireland)

See all devices from Depuy (Ireland) →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (9, all answered No)